Mark J. Ratain

BioTech

U.S. taxpayers should stop funding clinical trials of industry-owned drugs

The National Cancer Institute (NCI) has had a taxpayer-funded drug development program for nearly 70 years, initiated at a time when there was no private

Mark J. Ratain February 4, 2025

BioTech

The best way for the NIH to reduce drug prices is to address drug spending

As STAT reported recently, the Senate Committee on Health, Education, Labor, and Pensions (HELP) has indicated that it will not consider the nomination of Monica

Mark J. Ratain August 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.

Mark J. Ratain

U.S. taxpayers should stop funding clinical trials of industry-owned drugs

The best way for the NIH to reduce drug prices is to address drug spending

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

Subscribe